31st May 2006 15:56
GlaxoSmithKline PLC31 May 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. The Administrators of the GlaxoSmithKline US Retirement Savings Plan ("the Plan") notified GlaxoSmithKline plc on 31 May 2006, that as a result of a movement in the fund on 25 May 2006, the number of Ordinary Share ADRs held by the fund had changed from 17,425,862 to 17,411,245 at an average price of $56.44. The Plan is a discretionary fund of which all employees or former employees ofGlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three ofthe Company's directors, Dr J P Garnier, Dr T Yamada and Dr M Slaoui aretherefore potentially interested in the shares held in the fund from time totime in the same way as other employees or former employees of GlaxoSmithKlineplc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 31 May 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline